Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AACH
AAC
$0.03
+46.8%
$0.03
$0.01
$0.84
$805KN/A96,753 shs891,800 shs
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
$0.01
-3.4%
$0.01
$0.00
$0.01
$379K1.2240,236 shs11,010 shs
Mitesco, Inc. stock logo
MITI
Mitesco
$0.14
+7.6%
$0.23
$0.00
$1.00
$1.64M2.0754,152 shs6,413 shs
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
$0.19
+7.8%
$0.19
$0.14
$1.58
$1.23M1.73161,822 shs19,100 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AACH
AAC
0.00%0.00%0.00%0.00%0.00%
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
0.00%-3.36%+43.75%+91.99%+187.50%
Mitesco, Inc. stock logo
MITI
Mitesco
0.00%-10.00%-20.35%-52.53%-46.00%
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AACH
AAC
N/AN/AN/AN/AN/AN/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
N/AN/AN/AN/AN/AN/AN/AN/A
Mitesco, Inc. stock logo
MITI
Mitesco
N/AN/AN/AN/AN/AN/AN/AN/A
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AACH
AAC
0.00
N/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
0.00
N/AN/AN/A
Mitesco, Inc. stock logo
MITI
Mitesco
0.00
N/AN/AN/A
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AACH
AAC
N/AN/AN/AN/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
$30K12.63N/AN/A($0.99) per share-0.01
Mitesco, Inc. stock logo
MITI
Mitesco
$40K40.91N/AN/A($2.70) per share-0.05
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
$670K1.83N/AN/A$1.69 per share0.11
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AACH
AAC
N/AN/A0.00N/AN/AN/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
-$3.85M-$0.09N/AN/AN/AN/A-63.12%N/A
Mitesco, Inc. stock logo
MITI
Mitesco
-$2.51MN/A0.00N/A1,639.45%N/A-744.83%N/A
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
-$22.69MN/A0.00N/A-3,474.81%-151.82%-97.14%N/A

Latest FCHS, MITI, VYNT, and AACH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
N/A-$0.02N/A-$0.02N/AN/A
8/13/2025Q2 2025
Mitesco, Inc. stock logo
MITI
Mitesco
N/A-$0.01N/A-$0.01N/A$0.02 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AACH
AAC
N/AN/AN/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
N/AN/AN/AN/AN/A
Mitesco, Inc. stock logo
MITI
Mitesco
N/AN/AN/AN/AN/A
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AACH
AAC
N/AN/AN/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
N/AN/AN/A
Mitesco, Inc. stock logo
MITI
Mitesco
N/AN/AN/A
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
0.04
2.86
2.86

Institutional Ownership

CompanyInstitutional Ownership
AACH
AAC
N/A
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
N/A
Mitesco, Inc. stock logo
MITI
Mitesco
0.01%
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
N/A

Insider Ownership

CompanyInsider Ownership
AACH
AAC
31.22%
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
30.81%
Mitesco, Inc. stock logo
MITI
Mitesco
4.90%
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
9.56%
CompanyEmployeesShares OutstandingFree FloatOptionable
AACH
AAC
1,90025.16 millionN/ANot Optionable
First Choice Healthcare Solutions, Inc. stock logo
FCHS
First Choice Healthcare Solutions
20732.96 million22.80 millionNot Optionable
Mitesco, Inc. stock logo
MITI
Mitesco
3012.12 million11.52 millionNot Optionable
Vyant Bio, Inc. stock logo
VYNT
Vyant Bio
306.33 million5.72 millionNot Optionable

Recent News About These Companies

Vyant Bio (OTCMKTS:VYNT) Shares Up 7.8% - What's Next?
Bio vs non-bio washing powder
What is Biotechnology?
Vyant Bio Inc VYNT
Vyant Bio, Inc.: Vyant Bio Provides Update on Winddown Activities
Vyant Bio Provides Update on Winddown Activities
Namtu Airport, Namtu, Myanmar [ NMT / VYNT ]
Vyant Bio Announces Completion of StemoniX Asset Sale

AAC OTCMKTS:AACH

$0.03 +0.01 (+46.79%)
As of 12/14/2020

AAC Holdings, Inc. provides inpatient and outpatient substance use treatment services for individuals with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues in the United States. Its therapy services include motivational interviewing, cognitive behavioral therapy, rational emotive behavior therapy, dialectical behavioral therapy, solution-focused therapy, eye movement desensitization and reprocessing, and systematic family intervention. As of December 31, 2018, the company operated 11 inpatient substance abuse treatment facilities, focused on delivering clinical care and treatment solutions across 1,080 inpatient beds, including 700 licensed detoxification beds, 24 standalone outpatient centers, and 4 sober living facilities across 471 beds for a total of 1,551 combined inpatient and sober living beds. It also offers multi-media marketing services to families and individuals struggling with addiction and seeking treatment options through online directories of treatment providers, treatment provider reviews, forums, and professional communities. In addition, the company performs drug testing and diagnostic laboratory services; and provides physician services to its clients. AAC Holdings, Inc. was founded in 2014 and is headquartered in Brentwood, Tennessee. On June 20, 2020, AAC Holdings, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

First Choice Healthcare Solutions stock logo

First Choice Healthcare Solutions OTCMKTS:FCHS

$0.01 0.00 (-3.36%)
As of 08/29/2025 01:58 PM Eastern

First Choice Healthcare Solutions, Inc. provides healthcare services in the United States. It develops primary care and wellness clinics focused on providing life improvement services, such as anti-aging, weight management, hormone replacement, and pharmacy services. The company is headquartered in Melbourne, Florida.

Mitesco stock logo

Mitesco OTCMKTS:MITI

$0.14 +0.01 (+7.57%)
As of 08/29/2025 03:49 PM Eastern

Mitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.

Vyant Bio stock logo

Vyant Bio OTCMKTS:VYNT

$0.19 +0.01 (+7.78%)
As of 12/29/2023

Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). The company is based in Cherry Hill, New Jersey.